156 related articles for article (PubMed ID: 5608821)
21. [Temporary connection between coronary thrombosis and myocardial infarct].
Emmrich P
Z Gesamte Inn Med; 1970 Jan; 25(1):10-7. PubMed ID: 5522124
[No Abstract] [Full Text] [Related]
22. The impact of fibrinolytic therapy for ST-segment-elevation acute myocardial infarction.
Van de Werf FJ; Topol EJ; Sobel BE
J Thromb Haemost; 2009 Jan; 7(1):14-20. PubMed ID: 19090814
[TBL] [Abstract][Full Text] [Related]
23. Thrombosis: its role and prevention in cardiovascular events-Part II.
Harker LA; Thompson AR; Harlan JM
West J Med; 1981 Apr; 134(4):315-32. PubMed ID: 7018088
[No Abstract] [Full Text] [Related]
24. [The significance of coronary thrombosis in the etiology of myocardial infarct].
Gritsiuk AI
Vrach Delo; 1969 Jun; 6():16-21. PubMed ID: 5821656
[No Abstract] [Full Text] [Related]
25. Thrombolytic therapy of recent myocardial infarction. I. Introduction, plan of trial, general clinical results.
Schmutzler R; Heckner F; Kortge P; van der Loo J; Pezold A; Poliwoda H; Praetorius F; Zekorn D
Ger Med Mon; 1966 Aug; 11(8):308-14. PubMed ID: 5943926
[No Abstract] [Full Text] [Related]
26. [Treatment of myocardial infarction with ST-segment elevation].
Mohácsi A; Edes I; Czuriga I
Orv Hetil; 2004 Feb; 145(6):297-300. PubMed ID: 15038323
[No Abstract] [Full Text] [Related]
27. [The effect of anticoagulant therapy on the dynamics of electrocardiographic indices in patients with myocardial infarct].
Churin VD
Kardiologiia; 1968 Jul; 8(7):53-8. PubMed ID: 5697484
[No Abstract] [Full Text] [Related]
28. [Post-infarction evaluation and treatment in the era of fibrinolytics].
Sarmiento X; Guardiola JJ; Curos A
Med Clin (Barc); 1997 Feb; 108(5):186-96. PubMed ID: 9091724
[No Abstract] [Full Text] [Related]
29. [Antithrombotic therapy in the treatment of STEMI and NSTEMI patients].
Nikolić Heitzler V; Pavlov M; Babić Z; Bulj N
Acta Med Croatica; 2009 Feb; 63(1):117-9. PubMed ID: 19681476
[TBL] [Abstract][Full Text] [Related]
30. [Correction of thrombophilia].
Caruzzo C; Marcolongo M; Arpino E; Di Summa M
Minerva Cardioangiol; 1981; 29(1-2):13-8. PubMed ID: 6112717
[No Abstract] [Full Text] [Related]
31. [The main reasons for late diagnosis and errors in the early period of treatment of intrahospital myocardial infarction in a general hospital].
Ipatov PV; Ardashev VN; Chernov SA; Ovsiannikov VV
Klin Med (Mosk); 2006; 84(10):31-5. PubMed ID: 17201271
[TBL] [Abstract][Full Text] [Related]
32. [Therapy of heart infarct].
Strey W
Dtsch Krankenpflegez; 1972 Nov; 25(11):584-8. PubMed ID: 4485972
[No Abstract] [Full Text] [Related]
33. [Intervention in ischemic heart disease and myocardial infarction. 3. Medical intervention].
Pedersen A
Ugeskr Laeger; 1982 Jul; 144(29):2156-64. PubMed ID: 6128809
[No Abstract] [Full Text] [Related]
34. Aspirin after thrombolysis for MI.
Seaton TL
J Fam Pract; 1997 Mar; 44(3):249-50. PubMed ID: 9071241
[No Abstract] [Full Text] [Related]
35. [Clinical aspects of the fibrinolytic therapy of myocardial infarct].
Sterkowicz S
Wiad Lek; 1967 Jul; 20(13):1235-9. PubMed ID: 6056528
[No Abstract] [Full Text] [Related]
36. Reviparin in acute myocardial infarction.
Buccelletti F
JAMA; 2005 Jun; 293(21):2595. PubMed ID: 15928275
[No Abstract] [Full Text] [Related]
37. Reviparin in acute myocardial infarction.
Yan AT; Yan RT; Goodman SG
JAMA; 2005 Jun; 293(21):2595; author reply 2595-6. PubMed ID: 15928274
[No Abstract] [Full Text] [Related]
38. Low-molecular weight heparins.
Talley JD
J Ark Med Soc; 1997 Apr; 93(11):555-6. PubMed ID: 9114648
[No Abstract] [Full Text] [Related]
39. [Fibrinolytic treatment in the acute phase of myocardial infarct].
Guérot C; Laffay N
Rev Infirm; 1984 Apr; 34(7):55-9. PubMed ID: 6570901
[No Abstract] [Full Text] [Related]
40. [Therapy and prevention of thromboembolic diseases: anticoagulants and fibrinolytics].
Pelosio L; Marasco A; Puopolo G
Clin Ter; 1982 Feb; 100(4):417-25. PubMed ID: 7044661
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
